|
CCCC C4 Therapeutics, Inc 1662579 |
| Balance Sheet |
|
Current Assets
|
$245,371,000.00 |
|
Assets
|
$328,861,000.00 |
|
Current Liabilities
|
$27,249,000.00 |
|
Liabilities
|
$94,614,000.00 |
|
Equity
|
$234,247,000.00 |
|
Shares Out
|
104036350.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-29,944,000.00 |
|
Investing Cash Flow
|
$16,153,000.00 |
| Market Analysis |
Market Cap
|
$380,773,041.00 |
|
Price
|
$3.38 |
|
BVPS
|
2.25 |
|
PB
|
1.63 |
|
EPS
|
-0.20 |
|
PS
|
18.18 |
|
FCF
|
$-30,008,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:26 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.18 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-12 |
-0.20 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.37 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.44 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CCCC documents filed with the SEC.
CCCC Filings
Clear
